- FDA to end pilot aimed at preventing production issuesThe FDA said it will end a pilot that was intended to help drugmakers proactively address production issues. Few companies took advantage of the program during its three-year run. In April 2027,…Endpoints · 4d ago↗ source
- Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbumpAn unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy “contravenes decades of agency practice.”BioSpace · 4d ago↗ source
- Sartorius reduces revenue by €26M to refund Trump tariffs to customersSartorius appears to be the first life science company to detail how tariff refunds are affecting its revenue, following the US Supreme Court decision to block some of President Donald Trump’s levi…